To evaluate the effect of food on the Pharmacokinetics (PK) of AZD0328
Study identifier:D0190C00009
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I, Open, Randomized, Single-Dose, Two-Treatment (Fed versus Fasting), Two-Period Cross-Over Single-Centre Study to Evaluate the Effect of Food on the Pharmacokinetics of AZD0328 Following Oral Administration (Capsule) in Healthy Male Subjects
Medical condition
Healthy
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD0328
Sex
Male
Actual Enrollment
14
Study type
Interventional
Age
20 Years - 45 Years
Date
Study Start Date: 01 Sept 2008
Primary Completion Date: 01 Oct 2008
Study Completion Date: 01 Oct 2008
Study design
Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Other
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 AZD0328 administration during fasting condition | Drug: AZD0328 Oral capsule, single dose |
| Experimental: 2 AZD0328 administration after food intake | Drug: AZD0328 Oral capsule, single dose |
Contacts
Investigators
Principal Investigator
Didier Meulien
AstraZeneca R&D Södertälje, Sweden
